The slip
PARKINSON RECEIPTno. 6328
22 Oct 2026, 10:13 UTCdopamine neurons, braak
predictionAPEH in dopamine neurons tracks Braak Lewy-body stage
registerede19004d05eebe897
discovery+0.26 p=0.498 n=9
replication-0.16 p=0.685 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.26, p 0.498)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT9fe9a1b8592f4ed14fcec37f…
follows 9e87152c262e…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 6328: APEH in dopamine neurons, braak
- power
- full sample +0.05 (p 0.854, n 18), 95% CI -0.43 to +0.50. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.03 (p 0.901, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.09 (p 0.722, n 18). could be the mix.
- skeptic
- leave-one-out range -0.08 to +0.16, sign flips 3; without severely affected donors +0.05 (p 0.854, n 18). fragile.
- cell type
- strongest in OPCs: -0.70 (p 0.0012, n 18) vs +0.05 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for APEH in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up APEH · OPCs · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.68 p 0.016 (needs p < 3.2e-4)